Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model TauopathyClara Theunis, Andreas Muhs, David T. Hickman et al.|PLoS ONE|2013Cited by 253
Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic miceAndreas Muhs, Claude Nicolau, David T. Hickman et al.|Proceedings of the National Academy of Sciences|2007Cited by 176
P3‐281: The safety profile of ACI‐24, an oligo‐specific amyloid beta vaccine, demonstrated decrease of large microbleedings in brain of aged Alzheimer's disease mouse modelMaria Pihlgren, Katarzyna Stanco‐Piorko, Rime Madani et al.|Alzheimer s & Dementia|2009Cited by 3